MyAverix Finance MyAverix Finance

HK

Sipai Health Technology Co. Ltd. (314)

Sipai Health Technology Co. Ltd. (314) is listed on HK. As of 2026-05-21, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 314

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

Sipai Health Technology Co. Ltd. (314) — FAQ

What is 314's P/E ratio?

The price-to-earnings (P/E) ratio for Sipai Health Technology Co. Ltd. (314) is 18.00 (data as of 2026-05-21).

Does Sipai Health Technology Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Sipai Health Technology Co. Ltd. (314). Check the MyAverix Finance app for the latest dividend data.

What exchange is 314 listed on?

314 is listed on HK.

What is Sipai Health Technology Co. Ltd.'s net margin?

Sipai Health Technology Co. Ltd. (314) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play